openPR Logo
Press release

Antipsychotic Drugs Market: Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2025

04-15-2019 08:17 PM CET | Health & Medicine

Press release from: Allied Market Research

Antipsychotic Drugs Market: Huge Growth Opportunities |

Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of Schizophrenic patients. However, patent expiration of major brands could negatively impact market growth.

Download the Sample Report @ http://bit.ly/2v6L4X2

Deep-dive analysis of global antipsychotic drugs market focuses on major market dynamics such as drivers, restraints, and opportunities. Competitive landscape section profiles the key players on the basis of business performance, strategic moves and SWOT analysis. Profound analysis of segments would be helpful to understand the product distribution trends in each segment within the global antipsychotic drugs market.

High prevalence of Schizophrenia and psychotic disorders are the prime drivers for global antipsychotic drugs market. Increased drug abuse, over-prescription of drugs and addiction to antipsychotic drugs, are the additional factors that drive the market growth for antipsychotic drugs. However, patent expiry of major brands over the past few years had a negative impact on market growth and it has been responsible for the rising competition from a generic drug manufacturer. Serious side effects such as tardive dyskinesia, associated with antipsychotics also restraints market growth. Emerging economies are the opportunistic markets for antipsychotics due to a large pool of aging population, which has a high risk of psychosis, and increased healthcare awareness.

Global Antipsychotic Drugs Market by Brands

The global antipsychotic drugs market is segmented into three categories based on brands such as First, Second and Third generation antipsychotic drugs. Except for Halodol and lithium carbonate, all first-generation antipsychotic agents are called as standard or typical antipsychotics, as they act similar i.e., interference with neurotransmitters. Second generation antipsychotics are also known as atypical antipsychotic agents and act as broad-spectrum antagonists of dopamine, serotonin and alpha-noradrenergic receptors. With the development of technology and growing competition to gain the largest market share, researchers are focusing on first-generation antipsychotics to better understand their working mechanism. Abilify and Seroquel are topmost marketed brands due to their high therapeutic efficacy and reduced side effects.

Purchase the Report @20% Discount: http://bit.ly/2IBsRZp

Global Antipsychotic Drugs Market by Application

The global antipsychotic drugs are used to treat different brain disorders such as Schizophrenia, Bipolar disorder, Dementia, Unipolar Depression and Others. The drugs used in Schizophrenia and psychotic depression are expected to boost the growth of antipsychotic drugs market due to increasing incidences of these two conditions.

Global Antipsychotic Drugs Market by Geography

Geographically, the global antipsychotic drugs market is segmented into North America, Europe, Asia-Pacific, and LAMEA. Antipsychotics are the largely prescribed drugs in the North American region due to large patient pool suffering from mental and psychotic disorders. Asia-Pacific and LAMEA are the lucrative markets for global antipsychotic drugs manufacturers, due to the large patient pool and rising healthcare awareness.

Competitive Landscape

The key players within the global antipsychotic drugs market include Eli Lilly, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, and Johnson & Johnson. Patent expiration of major brands such as Zyprexa (by Eli Lilly) and Seroquel (by AstraZeneca) has negatively impacted the total revenue of this market. Generic competition is soaring due to the patent expiration of six largest antipsychotic drugs in 2012.

High-Level Analysis

The comprehensive analysis of global antipsychotic drugs market provides an overview of the market and its key concerns. Market segmentation is concentric towards product distribution trends of each segment that would be helpful to strategist in deciding on the market segments. Market dynamics covers market drivers, restraints and opportunities, which would help to understand the market behavior. Porter’s Five Forces analysis would be helpful in determining market profitability. Buyers bargaining power is high for global antipsychotic drugs market due to patent expiration of major brands and availability of many generic medicines in the marketplace. Global antipsychotic drugs market has a high threat from new entrants as major brands have lost their patent protection in 2012. Industrial rivalry is intense due to the entry of numerous generic competitors, which forces big players to manipulate their drug prices according to changing market trends.

KEY BENEFITS

This report offers the following benefits in particular:

Complete analysis of drivers restraints and opportunities within the global antipsychotic drugs market would assist professionals to understand the market behavior

Profound assessment of geography focuses on niche market areas and provides a forward-looking perspective

Porter’s Five Forces framework would assist strategist in decision making by analyzing the market profitability within global antipsychotic drugs market

Comprehensive assessment of key leaders and their market strategies for global antipsychotic drugs market would be informative to professionals in the corporate sector

KEY DELIVERABLES

The global antipsychotic drugs market is segmented into two major categories such as technology and geography.

MARKET BY BRANDS

First Generation Drugs (Standard / Typical Antipsychotic Agents)

Thorazine (Chlorpromazine HCl)

Serentil (Mesoridazine Besylate)

Mellaril (Thioridazine HCl)

Haldol (Haloperidol)

Loxitane (Loxapine Succinate)

Trilafon (Perphenazine)

Navane (Thiothixene)

Sordinol (Clopenthixol)

Others

Second generation Drugs (Atypical Antipsychotic Agents)

Zyprexa (Olanzapine)

Geodon (Ziprasidone)

Seroquel (Quetiapine)

Risperdal (Risperidone)

Clozaril (Clozapine)

Invega (Paliperidone)

Asendin (Amoxapine)

Latuda (Lurasidone)

Others

Third generation Drugs

Abilify (Aripiprazole)

MARKET BY APPLICATION

Schizophrenia

Bipolar Disorder

Dementia

Unipolar Depression

Other

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antipsychotic Drugs Market: Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2025 here

News-ID: 1703887 • Views: 633

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Antipsychotic

Antipsychotic Medications Market Size, Share, Development by 2024
New report published by Global Info Research which offers insights on the Global Antipsychotic Medications market. Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-antipsychotic-medications-market_p103541.html Global Antipsychotic Medications Market: Forecast by Type / Application / Region The worldwide market for Antipsychotic Medications is expected to
Antipsychotic Drugs Market, by Drug Type, Application, Distribution Channel
Anti-psychotic drugs, also called tranquilizers or neuroleptics, are a specific type of medication that are majorly used for the treatment of schizophrenia or bipolar disorder. They are used to manage psychosis, including hallucinations, delusions, and disordered thought of paranoia, among others. Anti-psychotic drugs are effective for the treatment of psychosis in a short duration. These drugs block the dopamine receptors in the dopaminergic pathways of the brain, thereby repressing the
Antipsychotic Drugs Market Enhancement in Medical Sector 2025
This report studies the global Antipsychotic Drugs market, analyzes and researches the Antipsychotic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline … Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/100987 Market segment by Regions/Countries, this report covers United States,EU,Japan,China,India,Southeast Asia Market segment by Type, the product can
A Comprehensive Research exploring Antipsychotic Drugs Market
HTF MI recently introduced Global Antipsychotic Drugs Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2022. At present, the market is developing its presence and some of the key players from the complete study are Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca & GlaxoSmithKline etc. The market Study is segmented by key regions which is accelerating the
Antipsychotic Drugs Market - Prominent Players,Growth and Forecast  2016 - 2024
Global Antipsychotic Drugs Market: Overview The global market for antipsychotic drugs is witnessing significant traction owing to the global rise in prevalence of psychotic disorders such as bipolar disorder, schizophrenia, delusions, hallucinations, and very severe depression (called “psychotic depression”). Recent studies have stated that antipsychotics are one of the top-selling and most widely prescribed drugs for managing psychotic conditions in the United States. Although earlier prescribed only for such psychotic conditions,
Global Antipsychotic drugs Detailed Analysis Report 2017-2022
This report splits Antipsychotic drugs by Product Antipsychotic drugs, Product Antidepressant anti-anxiety drugs. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Antipsychotic drugs industry. Major Companies